HCV: the journey from discovery to a cure. Volume 1 / Michael J. Sofia, editor ; with contributions by S.A. Alqahtani [and 39 others].
Sofia, Michael J., editor.; Alqahtani, S. A., author.
2019
RC848.H425
Available Online

Linked e-resources

Linked Resource
Online Access
Concurrent users
Unlimited
Authorized users
Authorized users
Document Delivery Supplied
Can lend chapters, not whole ebooks

Details

Title
HCV: the journey from discovery to a cure. Volume 1 / Michael J. Sofia, editor ; with contributions by S.A. Alqahtani [and 39 others].
ISBN
9783030282073 (electronic book)
3030282074 (electronic book)
DOI
https://doi.org/10.1007/978-3-030-28
Published
Cham, Switzerland : Springer, [2019]
Language
English
Description
1 online resource (viii, 463 pages).
Item Number
10.1007/978-3-030-28 doi
Call Number
RC848.H425
Dewey Decimal Classification
616.3623
Summary
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV) and infects approximately 75 million individuals worldwide. It is also one of the major causes of liver cancer and liver transplants. The elucidation of the HCV genome, and the development of a whole cell system to study the virus spurred the search for novel direct acting antiviral drugs to cure this disease. This global effort culminated in the development of direct acting antiviral drugs that led to cure rates approaching 100% in all patient populations after only 8-12 weeks of therapy. These efforts resulted in one of the greatest achievements in public health and provides the potential for eliminating HCV as a major disease worldwide. This volume is aimed at a broad audience of academic and industrial scientists interested in the discovery and development of drugs to treat viral diseases and those interested in reading about one of the most unique accomplishments in biomedical research. The volume will provide a one of a kind reference work that highlights the many efforts, from the discovery of the HCV virus, to the invention of breakthrough medicines and their use in the real world to cure patients. It is the companion book to the volume "HCV: The Journey from Discovery to a Cure - Volume II".
Bibliography, etc. Note
Includes bibliographical references and index.
Access Note
Access limited to authorized users.
Source of Description
Online resource; title from PDF title page (SpringerLink, viewed December 4, 2019).
Added Author
Sofia, Michael J., editor.
Alqahtani, S. A., author.
Series
Topics in medicinal chemistry (Springer (Firm)) ; v. 31.
Linked Resources
Online Access
Record Appears in
Online Resources > Ebooks
All Resources
Identification of the virus, the medical need and clearing the blood supply
Mapping the HCV genome
The molecular virology of HCV
The development of the HCV replicon system
The Evolution of IFN therapy for HCV
Evolution of HCV NS5B Non-Nucleoside Inhibitors
Evolution of HCV NS5B Nucleoside & Nucleotide Inhibitors
Discovery and Development of Sofosbuvir
Discovery of Beclabuvir
Discovery of Dasabuvir
Evolution of HCV NS3/4 protease inhibitors
Discovery and Development of Telaprevir
Discovery and Development of Boceprevir
Discovery and Development of Asunaprevir.-Discovery and Development of Grazoprevir
Discovery and Development of Simeprevir
Discovery and Development of Paritaprevir & Glecaprevir.

Browse Subjects

Show more subjects...

Statistics

from
to
Export